|
|
|
|
As an expert in your field, your resume is rich in experience and nuanced learnings and a well-written GLG profile serves as your GLG “resume,” helping us identify you as the right person for a GLG Project.
When we search GLG Profiles, if we can’t identify you by the places you’ve worked and the roles you’ve held, as well as the detail of your expertise, it’s very difficult to match you to relevant GLG Projects and to market you effectively to our clients. You might have the insight the client is looking for, but if we can’t find you readily, chances are we will be unable to send you the opportunity.
This easy-to-use explainer is designed to help you craft a GLG Profile that will function as GLG’s guide to all things about you, your career, and your knowledge. Follow these basic guidelines to build a GLG Profile that highlights your expertise to clients and helps us match you to the right Project.
|
|
|
|
Network Member Profile Tips |
Biography |
We don't recommend copying and pasting an existing biography or resume into your GLG Profile. Each entry should be augmented with detail that would be relevant to us, and our clients, as we search for the right expert.
- Write in complete sentences and follow this format for each relevant job from the past three to five years:
- Currently Employed NMs: [NM name] is currently [current job title] at [current employer] since [month and year]. [Current employer] is a [company description]. In this role, [first name] is responsible for [job responsibilities].
- Formerly Employed NMs: [NM name] was most recently [former job title] at [former employer] until [month and year]. [Former employer] is a [company description]. In this role, [first name] was responsible for [job responsibilities].
- Describe the NM’s responsibilities at the company. Be specific. Use industry-relevant keywords. This helps the NM be found by search algorithms for those terms.
- If there are important or unique accomplishments at any of their positions, include them using industry-specific keywords and specific examples of products or software they are familiar with, and include numerical data points whenever possible.
|
|
Work History |
A NM’s work history shows how they have built industry expertise. It’s important that a NM’s work history aligns with the information mentioned in their biography.
- Start chronologically from the most recent position and include the most up-to-date job title.
- Add all relevant previous roles from the past three to five years.
- However, if there are any important/unique roles that they have held (e.g., former government official) that are older than five years, include those as well. (But use good judgment — 1990 is no longer relevant!)
|
Bio Writing Style Tips
Write in complete sentences and in the third person. Use objective language to describe a NM and their work history.
Include date [month and year] for each job mentioned in the biography. Expand abbreviations and acronyms for industry terminology and associations on first mention. Proofread and correct typos or grammatical errors prior to sending a NM biography to a client. |
|
|
|
|
Sample Former Profile |
Peter Krotopkin most recently served as Regional VP and Partner at Atlantic Dental Services Inc., the second-largest dental group in the world, and largest private dental groupin the world, with more than 750 locations nationwideuntil 4/2021. In his role, he led operations for more than 25 dental practices and 500+ employees in IL, MO, and KS. Peter developed and executed operational and financial strategies for all practices in the market, and executed regional real estate strategies for more than five markets, taking retail dental locations from inception to operation. He also developed and partnered with more than 30 talented dentists to help them develop growing, successful practices. As Regional Operations Executive, Peter had direct P&L oversight for a $72 million business unit, with demonstrated skills in integrating operational strategies, building partnerships, and developing new revenue streams. He also managed KPIs and internal controls to monitor operational trends and devise forward-thinking solutions. |
|
Atlantic Dental Services Inc. |
Regional VP and Partner
5/2018–4/2021 |
|
Atlantic Dental Services Inc. |
National Director of New Market Content
5/2013–5/2018 |
|
Sample Currently Employed Profile |
Angelica Peterson is a Chief Product Officer at Blueberry ABM since May of 2018. Blueberry ABM is a full-service martech company valued at $50M. At Blueberry, Angelica built and maintained an account-based marketing platform for B2B marketers seeking to reach targeted accounts with digital advertising and content syndication. In her role, Angelica manages a $2M budget and 80+ employees. At Blueberry, Angelica has built the leading account-based marketing platform for serving digital advertising driven by intent data, competing with Bombora, Madison Logic, Demandbase, and Terminus.
Prior to this, Angelica spent five years (5/2013–4/2018) at Prometheus Software, a martech company serving B2B marketers looking to report on client behaviors, as SVP of Product. At Prometheus, Angelica focused on product/ software life cycle management in both start-up and growth organizations and created product road maps.
Angelica has led large product teams with budgets of more than $60M, with demonstrated skills in identifying new markets, product life cycle management, and product planning. She specializes in SEO (search engine optimization), ABM (account-based marketing) platforms, and CRM (customer relationship management). She’s familiar with software like Marketo, Asana, and Amazon Web Services. Her track record includes improving efficiencies, reducing costs, and increasing global market share, revenues, and profitability. |
|
Blueberry Account-Based Marketing |
Chief Product Officer
5/2018–Present |
|
Prometheus Software |
SVP Product
5/2013–4/2018 |
|
|
Sample Industry Consultant Profile |
Sandra J. Rodriguez is the President and Founder of ABC Water Advisory Inc., a firm that specializes in providing support to global water managers, solution providers, and investors for optimization of performance, development, and commercialization of advanced water technology products and systems. She retired at the end of 2010 from Walters Water Technologies Corp. (formerly USFilter) as the Chief Technology Officer, Senior Vice President, and a Member of the Executive Council Management Team. Sandra’s 40 years of experience in the water industry spans the spectrum of municipal, industrial, oil and gas production, commercial, marine, and residential water and wastewater treatment markets around the world. Her management responsibilities included new product rationalization and development processes, intellectual property, technology risk assessment, new venture commercialization strategies, and coordination with Walters Water’s global network of water technology research partners. During her tenure at Walters Water, Sandra served as chief water technology spokesman at numerous global water policy and technology conferences and panels. Prior to Walters Water’s acquisition of USFilter in 2000, Sandra served in a variety of senior management roles in support of USFilter’s rapid growth in the 1990s from $50 million to $5 billion in annual water technology and services revenue. Sandra is a past Board Member and Vice Chair of the Water Environment Research Foundation.
|
|
ABC Water Advisory Inc. |
President
2/2011-Present |
|
Walters Water Technologies Corp. |
Senior VP, Chief Technology Officer
9/2001-12/2010 |
|
Sample Healthcare Profile |
Melanie Nguyen, MD, is the Associate Director for Clinical Science at the Smith Cancer Center at the University of California at Irvine since 2/2016. She is also the Medical Director of the Pacific Center for Clinical Trials & Research since 2/2016. She is an expert in leukemia research, specializing in the biology of and therapy for chronic lymphocytic leukemia (CLL) and chronic myelocytic leukemia (CML). Dr. Nguyen’s research interests include development of novel agents and combination strategies for chronic leukemias and ALL. She has participated in many clinical trials, including those involving combination and monoclonal antibody therapies for CLL and minimal residual disease, imids, and B-cell receptor inhibitors. Her research efforts in CML include participating in studies involving TKIs as well as new drugs such as omacetaxine and ponatinib. Her interest in ALL includes involvement with trials utilizing novel monoclonal antibodies including blinatumomab and inotuzumab. Dr. Nguyen is an advisor to the CLL Global Research Foundation, serves on the Scientific Advisory Board for the Leukemia and Lymphoma Society, and is the SWOG executive officer with responsibility to oversee leukemia, lymphoma, and myeloma clinical research. |
|
University of California, Irvine |
Associate Director for Clinical Science, Medical Director
5/2018–Present
1/2015-Present |
|
|
|
|
|
|
|
|
